乐普生物-B(02157)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02157 乐普生物-B

提前休市 12-24 12:08:29

2.650

+0.000

0.00%

最高2.710	最低2.580	成交量753.40万
今开2.680	昨收2.650	日振幅4.91%
总市值45.33亿	流通市值43.88亿	总股本17.11亿
成交额1,983万	换手率0.45%	流通股本16.56亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02157","market":"HK","secType":"STK","nameCN":"乐普生物-B","latestPrice":2.65,"timestamp":1735013309013,"preClose":2.65,"halted":0,"volume":7534000,"delay":0,"floatShares":1655999999,"shares":1710614838,"eps":-0.01416284,"marketStatus":"提前休市","marketStatusCode":6,"change":0,"latestTime":"12-24 12:08:29","open":2.68,"high":2.71,"low":2.58,"amount":19831800,"amplitude":0.049057,"askPrice":2.65,"askSize":2000,"bidPrice":2.61,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":-0.04639965537816106,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735263000000},"adr":0,"listingDate":1645545600000,"adjPreClose":2.65,"openAndCloseTimeList":[[1735003800000,1735012800000]],"volumeRatio":0.649106,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02157","defaultTab":"news","newsList":[{"id":"2493746849","title":"【券商聚焦】太平洋证券首予乐普生物(02157)“买入”评级 指ADC管线即将进入收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2493746849","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493746849?lang=zh_cn&edition=full","pubTime":"2024-12-24 08:56","pubTimestamp":1735001810,"startTime":"0","endTime":"0","summary":"金吾财讯 | 太平洋证券发研报指，乐普生物 围绕PD-1精准匹配，打造多样化、全面的联合用药组合：围绕“PD-1+ADC”前瞻布局，目前EGFRADC、HER2ADC联合PD-1治疗方案已处于二期临床阶段；溶瘤病毒CG0070和PD-1联用在非肌浸润性膀胱癌适应症上的临床试验在准备临床阶段。该行表示，乐普生物的普特利单抗2022年开始商业化，并通过和ADC联合用药不断拓展新的适应症，增厚收入。该行续指，公司多款FIC潜质药物在研，ADC管线即将进入收获期。首次覆盖，给予“买入”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MDc2YjQxZmY4Y2VkNWEzNDU4MmJiNGExMDgxOTA3MjUwMzc=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1950191","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["601099","02157","ADC","161027"],"gpt_icon":0},{"id":"2493738648","title":"乐普生物-B12月23日主力资金流出7万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2493738648","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493738648?lang=zh_cn&edition=full","pubTime":"2024-12-23 16:16","pubTimestamp":1734941816,"startTime":"0","endTime":"0","summary":"12月23日, 乐普生物-B股价跌11.07%，报收2.65元，成交金额6132万元，换手率1.36%，振幅14.77%，量比1.01。乐普生物-B今日主力资金净流出7万元，连续3日净流出，上一交易日主力净流出137万元，今日环比减少94.89%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为62.50%，平均跌幅为3.52%。该股近5个交易日下跌0.38%，主力资金累计净流入1187万元；近20日主力资金累计净流入196万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223161732ab8d67f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223161732ab8d67f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2493205431","title":"乐普生物-B盘中异动 快速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493205431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493205431?lang=zh_cn&edition=full","pubTime":"2024-12-23 10:54","pubTimestamp":1734922445,"startTime":"0","endTime":"0","summary":"2024年12月23日早盘10时54分，乐普生物-B股票出现异动，股价快速跳水5.03%。截至发稿，该股报2.830港元/股，成交量324.2万股，换手率0.20%，振幅6.71%。乐普生物-B股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，腾盛博药-B、嘉和生物-B、永泰生物-B涨幅较大，振幅较大的相关个股有晶泰控股-P、康诺亚-B、宜明昂科-B，振幅分别为9.73%、8.44%、7.55%。乐普生物-B公司简介：乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122310540595eacad9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122310540595eacad9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2493120553","title":"乐普生物-B(02157)下跌5.03%，报2.83元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2493120553","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493120553?lang=zh_cn&edition=full","pubTime":"2024-12-23 10:54","pubTimestamp":1734922444,"startTime":"0","endTime":"0","summary":"12月23日，乐普生物-B(02157)盘中下跌5.03%，截至10:54，报2.83元/股，成交941.4万元。乐普生物科技股份有限公司主要市场在中国，专注于肿瘤治疗领域的生物制药研发，特别在靶向治疗及免疫治疗上有创新成果。该公司拥有完整的药物发现、临床开发、CMC及GMP合规生产的端到端能力，并已经建立了专业的销售和营销团队，旨在满足临床需求，提供优化和创新的药物解决方案。截至2024年中报，乐普生物-B营业总收入1.33亿元、净利润-1.92亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/23105446686902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2492456360","title":"乐普生物-B盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492456360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492456360?lang=zh_cn&edition=full","pubTime":"2024-12-20 09:57","pubTimestamp":1734659841,"startTime":"0","endTime":"0","summary":"2024年12月20日早盘09时57分，乐普生物-B股票出现波动，股价大幅跳水5.10%。截至发稿，该股报2.980港元/股，成交量275.4万股，换手率0.17%，振幅8.60%。乐普生物-B股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，歌礼制药-B、药明合联、北海康成-B涨幅较大，振幅较大的相关个股有北海康成-B、歌礼制药-B、乐普生物-B，振幅分别为18.30%、16.67%、8.60%。乐普生物-B公司简介：乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220095721a1fc75f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220095721a1fc75f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2492455860","title":"乐普生物-B(02157)下跌5.1%，报2.98元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492455860","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492455860?lang=zh_cn&edition=full","pubTime":"2024-12-20 09:57","pubTimestamp":1734659836,"startTime":"0","endTime":"0","summary":"12月20日，乐普生物-B(02157)盘中下跌5.1%，截至09:57，报2.98元/股，成交842.03万元。乐普生物科技股份有限公司主要市场在中国，专注于肿瘤治疗领域的生物制药研发，特别在靶向治疗及免疫治疗上有创新成果。该公司拥有完整的药物发现、临床开发、CMC及GMP合规生产的端到端能力，并已经建立了专业的销售和营销团队，旨在满足临床需求，提供优化和创新的药物解决方案。截至2024年中报，乐普生物-B营业总收入1.33亿元、净利润-1.92亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/20095746620664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2492951151","title":"乐普生物-B盘中异动 快速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492951151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492951151?lang=zh_cn&edition=full","pubTime":"2024-12-19 10:17","pubTimestamp":1734574678,"startTime":"0","endTime":"0","summary":"2024年12月19日早盘10时17分，乐普生物-B股票出现波动，股价急速拉升5.18%。截至发稿，该股报3.450港元/股，成交量498.8万股，换手率0.30%，振幅7.01%。乐普生物-B股票所在的生物技术行业中，整体跌幅为1.09%。其相关个股中，来凯医药-B、乐普生物-B、云康集团涨幅较大，振幅较大的相关个股有来凯医药-B、晶泰控股-P、永泰生物-B，振幅分别为18.50%、13.59%、12.28%。乐普生物-B公司简介：乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121910175895ea652c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121910175895ea652c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2492723529","title":"乐普生物-B12月18日主力资金流入494万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2492723529","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492723529?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:16","pubTimestamp":1734509769,"startTime":"0","endTime":"0","summary":"12月18日, 乐普生物-B股价涨6.49%，报收3.28元，成交金额8135万元，换手率1.55%，振幅16.56%，量比1.87。乐普生物-B今日主力资金净流入494万元，连续3日净流入，上一交易日主力净流入931万元，今日环比减少46.94%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为50.00%，平均涨幅为2.68%。该股近5个交易日上涨22.39%，主力资金累计净流入1427万元；近20日主力资金累计净流入480万元，其中净流入天数为10日。该股主力净额占比0.09%，港股市场排名63/2653。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218161650ab8147be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218161650ab8147be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2492920712","title":"港股异动 | 乐普生物-B(02157)再涨超11% MRG003有望25年下半年获批 TP ADC海外授权潜力大","url":"https://stock-news.laohu8.com/highlight/detail?id=2492920712","media":"智通财经网","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492920712?lang=zh_cn&edition=full","pubTime":"2024-12-18 14:57","pubTimestamp":1734505059,"startTime":"0","endTime":"0","summary":"乐普生物-B(02157)昨日放量涨超16%，今日午后再涨超11%，截至发稿，涨9.09%，报3.36港元，成交额6939.69万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20241218/20241218145750_64762.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20241218/20241218145750_64762.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226433.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4231","BK4080","02157","ADC","BK1161"],"gpt_icon":0},{"id":"2492923987","title":"乐普生物-B(02157)上涨5.19%，报3.24元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492923987","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492923987?lang=zh_cn&edition=full","pubTime":"2024-12-18 11:52","pubTimestamp":1734493966,"startTime":"0","endTime":"0","summary":"12月18日，乐普生物-B(02157)盘中上涨5.19%，截至11:52，报3.24元/股，成交3839.36万元。乐普生物科技股份有限公司主要市场在中国，专注于肿瘤治疗领域的生物制药研发，特别在靶向治疗及免疫治疗上有创新成果。该公司拥有完整的药物发现、临床开发、CMC及GMP合规生产的端到端能力，并已经建立了专业的销售和营销团队，旨在满足临床需求，提供优化和创新的药物解决方案。截至2024年中报，乐普生物-B营业总收入1.33亿元、净利润-1.92亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/18115246525599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2492392597","title":"乐普生物-B盘中异动 临近午盘急速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492392597","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492392597?lang=zh_cn&edition=full","pubTime":"2024-12-18 11:52","pubTimestamp":1734493960,"startTime":"0","endTime":"0","summary":"2024年12月18日临近午盘11时52分，乐普生物-B股票出现异动，股价急速上涨5.19%。乐普生物-B股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，歌礼制药-B、圣诺医药-B、乐普生物-B涨幅较大，振幅较大的相关个股有北海康成-B、圣诺医药-B、创胜集团-B，振幅分别为28.66%、19.06%、18.97%。乐普生物-B公司简介：乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121811524095ea42ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121811524095ea42ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2492892538","title":"乐普生物－Ｂ(02157)股价上升5.195%，现价港币$3.24","url":"https://stock-news.laohu8.com/highlight/detail?id=2492892538","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492892538?lang=zh_cn&edition=full","pubTime":"2024-12-18 11:52","pubTimestamp":1734493920,"startTime":"0","endTime":"0","summary":"[上升股]乐普生物－Ｂ(02157) 股价在上午11:52比前收市价上升5.195%，现股价为港币$3.24。至目前为止，今日最高价为$3.24，而最低价为$2.93。总成交量为1.248千万股，总成交金额为港币$3.796千万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241218935/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2492393559","title":"乐普生物与乐普医疗CDMO服务关联交易预计2025年上限为3600万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492393559","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492393559?lang=zh_cn&edition=full","pubTime":"2024-12-17 17:14","pubTimestamp":1734426850,"startTime":"0","endTime":"0","summary":"财中社12月17日电乐普生物-B（02157）发布公告，提及与乐普医疗签订的CDMO服务框架协议，该协议于2024年11月26日达成，内容包括为乐普医疗及其附属公司提供药物开发相关的CDMO服务及设备。协议的有效期为2025年1月1日至2025年12月31日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412173270896942.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02157","CDMO","BK4139"],"gpt_icon":0},{"id":"2492705987","title":"乐普生物-B12月17日获主力加仓931万元 环比增加464.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492705987","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492705987?lang=zh_cn&edition=full","pubTime":"2024-12-17 16:15","pubTimestamp":1734423308,"startTime":"0","endTime":"0","summary":"12月17日, 乐普生物-B股价涨16.23%，报收3.08元，成交金额1.29亿元，换手率2.65%，振幅17.74%，量比7.84。乐普生物-B今日主力资金净流入931万元，上一交易日主力净流入165万元，今日环比增加464.24%。该股近5个交易日上涨18.68%，主力资金累计净流入983万元；近20日主力资金累计净流入37万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217161517a1f54172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217161517a1f54172&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2492984205","title":"港股异动 | 乐普生物-B(02157)盘中涨超18% ADC再现重磅出海交易 机构称TF ADC海外授权潜力大","url":"https://stock-news.laohu8.com/highlight/detail?id=2492984205","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492984205?lang=zh_cn&edition=full","pubTime":"2024-12-17 15:34","pubTimestamp":1734420878,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，乐普生物-B盘中涨超18%，截至发稿，涨16.23%，报3.08港元，成交额1.17亿港元。国投证券此前指出，TF ADC早期数据优异，海外授权潜力大。乐普生物TF ADC已在ASCO 2024年会上披露了针对胰腺癌的优异数据，考虑到该领域严重的未满足临床需求，我们认为其海外授权潜力大。值得注意的是，乐普生物9月份公布，MRG003用于治疗复发性/转移性鼻咽癌新药上市申请获国家药监局受理并纳入优先审评。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4080","02157","BK1161","ADC","BK4231"],"gpt_icon":0},{"id":"2492672825","title":"部分港股医药股走强 乐普生物涨近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492672825","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492672825?lang=zh_cn&edition=full","pubTime":"2024-12-17 09:49","pubTimestamp":1734400186,"startTime":"0","endTime":"0","summary":"每经AI快讯，12月17日，截至发稿，乐普生物(02157.HK)涨5.66%、云康集团(02325.HK)涨5.56%、康希诺生物(06185.HK)涨4.01%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202412173270279363.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412173270279363.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2492801674","title":"乐普生物-B盘中异动 股价大涨5.66%报2.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492801674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492801674?lang=zh_cn&edition=full","pubTime":"2024-12-17 09:32","pubTimestamp":1734399159,"startTime":"0","endTime":"0","summary":"2024年12月17日早盘09时32分，乐普生物-B股票出现波动，股价大幅上涨5.66%。截至发稿，该股报2.800港元/股，成交量68万股，换手率0.04%，振幅5.66%。资金方面，该股资金流入93.254万港元，流出23.853万港元。乐普生物-B股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，乐普生物-B、云康集团、复宏汉霖涨幅较大，振幅较大的相关个股有晶泰控股-P、乐普生物-B、科济药业-B，振幅分别为7.53%、5.66%、3.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217093239ab7dbe49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217093239ab7dbe49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2491630679","title":"乐普生物-B盘中异动 下午盘股价大涨6.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491630679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491630679?lang=zh_cn&edition=full","pubTime":"2024-12-16 14:53","pubTimestamp":1734332015,"startTime":"0","endTime":"0","summary":"2024年12月16日下午盘14时53分，乐普生物-B股票出现异动，股价大幅上涨6.61%。截至发稿，该股报2.740港元/股，成交量518.7万股，换手率0.31%，振幅9.73%。乐普生物-B股票所在的生物技术行业中，整体跌幅为1.43%。乐普生物-B公司简介：乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121614533595ea071c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121614533595ea071c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02157"],"gpt_icon":0},{"id":"2491637758","title":"乐普生物-B(02157)上涨6.61%，报2.74元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491637758","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491637758?lang=zh_cn&edition=full","pubTime":"2024-12-16 14:53","pubTimestamp":1734332012,"startTime":"0","endTime":"0","summary":"12月16日，乐普生物-B(02157)盘中上涨6.61%，截至14:53，报2.74元/股，成交1343.06万元。乐普生物科技股份有限公司主要市场在中国，专注于肿瘤治疗领域的生物制药研发，特别在靶向治疗及免疫治疗上有创新成果。该公司拥有完整的药物发现、临床开发、CMC及GMP合规生产的端到端能力，并已经建立了专业的销售和营销团队，旨在满足临床需求，提供优化和创新的药物解决方案。截至2024年中报，乐普生物-B营业总收入1.33亿元、净利润-1.92亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/16145346414150.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02157","BK1161"],"gpt_icon":0},{"id":"2491563029","title":"乐普生物－Ｂ(02157)股价上升5.058%，现价港币$2.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2491563029","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491563029?lang=zh_cn&edition=full","pubTime":"2024-12-16 14:53","pubTimestamp":1734331980,"startTime":"0","endTime":"0","summary":"[上升股]乐普生物－Ｂ(02157) 股价在下午02:53比前收市价上升5.058%，现股价为港币$2.7。至目前为止，今日最高价为$2.7，而最低价为$2.49。总成交量为480.7万股，总成交金额为港币$1.24千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190212132919673_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241216986/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02157"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lepubiopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0569},{"period":"3month","weight":-0.1017},{"period":"6month","weight":-0.3358},{"period":"1year","weight":-0.2472},{"period":"ytd","weight":-0.3705}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0464},{"period":"6month","weight":0.0991},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.1663}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"乐普生物科技股份有限公司是一家专注于肿瘤治疗领域的中国生物制药公司。该公司主要研发肿瘤候选药物的产品管线，包括处于临床及临床前阶段的ADC、溶瘤病毒药物及免疫疗法。该公司主要在研管线资产包括MRG003、MRG002、HX008及LP002，及三种关键临床阶段候选药物。该公司产品销往海内外市场。","exchange":"SEHK","name":"乐普生物-B","nameEN":"LEPU BIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"乐普生物-B(02157)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供乐普生物-B(02157)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"乐普生物-B,02157,乐普生物-B股票,乐普生物-B股票老虎,乐普生物-B股票老虎国际,乐普生物-B行情,乐普生物-B股票行情,乐普生物-B股价,乐普生物-B股市,乐普生物-B股票价格,乐普生物-B股票交易,乐普生物-B股票购买,乐普生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"乐普生物-B(02157)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供乐普生物-B(02157)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}